Search results for PX-TA1067
Showing 1 – 10 of1products
ID: BAB991249933
Blinatumomab Biosimilar – Anti-CD19, CD3E mAb – Research Grade, ProteoGenix, PX-TA1067
Description of Blinatumomab Biosimilar - Anti-CD19, CD3E mAb - Research Grade General information on Anti-CD19/CD3E(Homo sapiens) (Blinatumomab) Monoclonal Antibody Blinatumomab is a monoclonal antibody constructed by BiTE (bispecific T cell engagers), which is used to treat relapsed or refractory B cell precursor acute lymphoblastic leukemia (ALL) with negative Philadelphia chromosome. Blinatumomab is available as a drug under the Blincyto™ brand.
Host
Reactivity
Applications
Conjugation
Request a product
Please provide the required information below so that we can quickly source your products.